Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 15;35(4):F1-F10.
doi: 10.1097/QAD.0000000000002836.

Risk of adverse coronavirus disease 2019 outcomes for people living with HIV

Maya M Mellor  1 , Anne C Bast  1 , Nicholas R Jones  2 , Nia W Roberts  3 , José M Ordóñez-Mena  2   4 , Alastair J M Reith  1 , Christopher C Butler  2 , Philippa C Matthews  5   6 , Jienchi Dorward  2   7
Affiliations
Review

Risk of adverse coronavirus disease 2019 outcomes for people living with HIV

Maya M Mellor et al. AIDS. .

Abstract

Objective: To assess whether people living with HIV (PLWH) are at increased risk of coronavirus disease 2019 (COVID-19) mortality or adverse outcomes, and whether antiretroviral therapy (ART) influences this risk.

Design: Rapid review with meta-analysis and narrative synthesis.

Methods: We searched databases including Embase, Medline, medRxiv and Google Scholar up to 26 August 2020 for studies describing COVID-19 outcomes in PLWH and conducted a meta-analysis of higher quality studies.

Results: We identified 1908 studies and included 19 in the review. In a meta-analysis of five studies, PLWH had a higher risk of COVID-19 mortality [hazard ratio 1.95, 95% confidence interval (CI): 1.62-2.34] compared with people without HIV. Risk of death remained elevated for PLWH in a subgroup analysis of hospitalized cohorts (hazard ratio 1.60, 95% CI: 1.12-2.27) and studies of PLWH across all settings (hazard ratio 2.08, 95% CI: 1.69-2.56). Eight other studies assessed the association between HIV and COVID-19 outcomes, but provided inconclusive, lower quality evidence due to potential confounding and selection bias. There were insufficient data on the effect of CD4+ T-cell count and HIV viral load on COVID-19 outcomes. Eleven studies reported COVID-19 outcomes by ART-regimen. In the two largest studies, tenofovir disoproxil fumarate-based regimens were associated with a lower risk of adverse COVID-19 outcomes, although these analyses are susceptible to confounding by co-morbidities.

Conclusion: Emerging evidence suggests a moderately increased risk of COVID-19 mortality among PLWH. Further investigation into the relationship between COVID-19 outcomes and CD4+ T-cell count, HIV viral load, ART and the use of tenofovir disoproxil fumarate is warranted.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram to show studies identified and included in a systematic meta-analysis of outcomes of coronavirus disease 2019 in people living with HIV.
Fig. 2
Fig. 2
Meta-analysis of the effect of HIV on risk of coronavirus disease 2019 death.
See this image and copyright information in PMC

Comment in

References

    1. World Health Organization (WHO). Weekly operational update on COVID-19, 21 August 2020. 2020; Geneva: World Health Organization (WHO), Available at: https://www.who.int/publications/m/item/weekly-update-on-covid-19---21-a.... [Accessed 18 January 2021].
    1. Sudharsanan N, Didzun O, Bärnighausen T, Geldsetzer P. The contribution of the age distribution of cases to COVID-19 case fatality across countries. Ann Intern Med 2020; 173:714–720. - PMC - PubMed
    1. Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. . Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open 2020; 3:e2012270. - PMC - PubMed
    1. World Health Organization. HIV/AIDS fact sheet. 2020; Geneva: World Health Organization, Available at: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. [Accessed 18 January 2021].
    1. Williamson E, Walker AJ, Bhaskaran KJ, Bacon S, Bates C, Morton CE, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584:430–436. - PMC - PubMed